Updated: Wed, 10/02/2024 - 13:45

From Saturday, Oct. 5 through Monday, Oct. 7, the Downtown and Macdonald Campuses will be open only to McGill students, employees and essential visitors. Many classes will be held online. Remote work required where possible. See Campus Public Safety website for details.

Du samedi 5 octobre au lundi 7 octobre, le campus du centre-ville et le campus Macdonald ne seront accessibles qu’aux étudiants et aux membres du personnel de l’Université McGill, ainsi qu’aux visiteurs essentiels. De nombreux cours auront lieu en ligne. Le personnel devra travailler à distance, si possible. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

Home / People

Moulay A Alaoui-Jamali

Academic title(s): 

Full Member, McGill Centre for Translational Research in Cancer
Professor, Department of Medicine, Division of Experimental Medicine, McGill University
Professor, Departments of Oncology, and Pharmacology and Therapeutics, McGill University
Senior Scientist, Lady Davis Institute for Medical Research

Moulay A Alaoui-Jamali
Contact Information
Address: 

Lady Davis Institute for Medical Research
Jewish General Hospital
3755 Côte Ste-Catherine Road
Montreal, Quebec H3T 1E2

Phone: 
514-340-8260 Ext 3438
Email address: 
moulay.alaoui-jamali [at] mcgill.ca
Group: 
Biomarker/biopsy-driven research towards personalized medicine
Molecular modeling and new drug development: Development of Biological and Chemical Agents
Link(s): 
Dr. Jamali's profile at the Lady Davis Institute for Medical Research
Dr. Jamali's profile at the Division of Experimental Medicine, McGill University
Current research: 

Dr. Jamali's research programs are in the biology of cancer progression to metastasis, anticancer drug pharmacology, and preclinical cancer models for discovery of innovative therapeutics. His laboratory is using advanced genomic technologies to understand metastasis signaling and identify novel targets and selective agents for therapeutic intervention. Another focus of his research is to understand and tackle drug resistance mechanisms associated with clinical relapses seen with most clinically used therapeutics.

 
Back to top